Search - tctmd.com

Displaying 181 - 200 of 298

Sort: Relevancy | Date

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Shelley Wood

April 16, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

News Daily News

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

Todd Neale

April 03, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Conference News STS 2019

TAVR Outcomes Dependent on SAVR Hospital Volumes

Yael L. Maxwell

January 28, 2019

News Daily News

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Caitlin E. Cox

January 04, 2019

News Daily News

Better TAVR Outcomes With More Experienced Operators: New York Database

Michael O'Riordan

December 12, 2018

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Shelley Wood

September 11, 2018

News Conference News PCR London Valves 2018

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Shelley Wood

September 10, 2018

News Conference News ESC 2018

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Yael L. Maxwell

September 06, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

Advertisement

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Latest Observational Data Support TAVR Durability Through 7 Years

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

TAVR Outcomes Dependent on SAVR Hospital Volumes

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Better TAVR Outcomes With More Experienced Operators: New York Database

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content